Free Trial
→ I was right about SpaceX (From Brownstone Research) (Ad)tc pixel
NASDAQ:HYPR

Hyperfine Q1 2026 Earnings Report

Hyperfine logo
$1.71 -0.10 (-5.58%)
Closing price 03:59 PM Eastern
Extended Trading
$1.71 +0.00 (+0.06%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Hyperfine EPS Results

Actual EPS
N/A
Consensus EPS
-$0.09
Beat/Miss
N/A
One Year Ago EPS
N/A

Hyperfine Revenue Results

Actual Revenue
N/A
Expected Revenue
$3.54 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Hyperfine Announcement Details

Quarter
Q1 2026
Date
5/12/2026
Time
After Market Closes
Conference Call Date
Tuesday, May 12, 2026
Conference Call Time
4:30PM ET

Conference Call Resources

Hyperfine Earnings Headlines

BTIG Research Begins Coverage on Hyperfine (NASDAQ:HYPR)
May 1, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30751023
BTIG initiates coverage of Hyperfine (HYPR) with buy recommendation
April 30, 2026  |  msn.comhttps://www.msn.com/en-us/money/technology/btig-initiates-coverage-of-hyperfine-hypr-with-buy-recommendation/ar-AA223yjc
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.tc pixel
May 5 at 1:00 AM  |  Brownstone Research (Ad)
Hyperfine Swoop® System Introduced as India’s First Portable MRI for Bedside Brain Imaging at the Country’s Leading Medical Institution
April 29, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/hyperfine-swoop-system-introduced-india-121500804.html
Hyperfine Swoop® System Introduced as India's First Portable MRI for Bedside Brain Imaging at the Country's Leading Medical Institution
April 29, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260429706357/en/hyperfine-swoop%c2%ae-system-introduced-as-india%e2%80%99s-first-portable-mri-for-bedside-brain-imaging-at-the-country%e2%80%99s-leading-medical-institution/
Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026
April 28, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260428615786/en/hyperfine-inc.-to-announce-first-quarter-2026-financial-results-on-may-12-2026/
See More Hyperfine Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hyperfine? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hyperfine and other key companies, straight to your email.

About Hyperfine

Hyperfine (NASDAQ:HYPR) (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients. Hyperfine’s portable MRI is configured for rapid, point-of-care imaging of the brain and central nervous system, with applications spanning stroke evaluation, traumatic brain injury assessment and routine neurological monitoring. The system’s cloud-based image management and AI-assisted processing tools help streamline workflow and accelerate diagnostic decision-making.

Founded in 2014 and headquartered in Guilford, Connecticut, Hyperfine secured U.S. Food and Drug Administration 510(k) clearance for its portable MRI in 2020 and obtained CE mark authorization for its European operations in 2021. The company completed its business combination and began trading publicly on Nasdaq in 2022. Hyperfine continues to expand its commercial footprint across the United States and selective international markets, partnering with hospitals, health systems and research institutions to integrate portable MRI into standard clinical practice.

View Hyperfine Profile
Earnings Tools